Effects of Add on Pegylated Interferon therapy in patients of Chronic hepatitis B in maintained response with ongoing nucleos(t)ide analogues ; A multicenter, prospective, randomized open label trial.

drug protocol number
RC14-055-R
drug sponsor
KAIMRC
drug study
PEGINTERFERON ALFA-2A, RO258310 RIBAVIRIN, R0209963
drug trial site
NGHA-R
drug status
Ongoing
drug phase